[go: up one dir, main page]

CL2012003579A1 - Procedimiento de sintesis de la ivabradina de formula (i) y de sus sales de adicion a un acido farmaceuticamente aceptable. - Google Patents

Procedimiento de sintesis de la ivabradina de formula (i) y de sus sales de adicion a un acido farmaceuticamente aceptable.

Info

Publication number
CL2012003579A1
CL2012003579A1 CL2012003579A CL2012003579A CL2012003579A1 CL 2012003579 A1 CL2012003579 A1 CL 2012003579A1 CL 2012003579 A CL2012003579 A CL 2012003579A CL 2012003579 A CL2012003579 A CL 2012003579A CL 2012003579 A1 CL2012003579 A1 CL 2012003579A1
Authority
CL
Chile
Prior art keywords
ivabradine
formula
pharmaceutically acceptable
addition salts
acceptable acid
Prior art date
Application number
CL2012003579A
Other languages
English (en)
Inventor
Renaud Jean-Luc
Pannetier Nicolas
Lecouve Jean-Pierre
Gaillard Sylvain
Vaysse-Ludot Licile
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47355960&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2012003579(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of CL2012003579A1 publication Critical patent/CL2012003579A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CL2012003579A 2011-12-20 2012-12-19 Procedimiento de sintesis de la ivabradina de formula (i) y de sus sales de adicion a un acido farmaceuticamente aceptable. CL2012003579A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1103934A FR2984320B1 (fr) 2011-12-20 2011-12-20 Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Publications (1)

Publication Number Publication Date
CL2012003579A1 true CL2012003579A1 (es) 2014-09-05

Family

ID=47355960

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012003579A CL2012003579A1 (es) 2011-12-20 2012-12-19 Procedimiento de sintesis de la ivabradina de formula (i) y de sus sales de adicion a un acido farmaceuticamente aceptable.

Country Status (34)

Country Link
US (1) US8507668B2 (es)
EP (1) EP2607354B1 (es)
JP (1) JP5531084B2 (es)
KR (1) KR101479986B1 (es)
CN (1) CN103172567B (es)
AR (1) AR089325A1 (es)
AU (1) AU2012261583B2 (es)
BR (1) BR102012032562A2 (es)
CA (1) CA2798633C (es)
CL (1) CL2012003579A1 (es)
CY (1) CY1115620T1 (es)
DK (1) DK2607354T3 (es)
EA (1) EA021713B1 (es)
ES (1) ES2516290T3 (es)
FR (1) FR2984320B1 (es)
GE (1) GEP20156245B (es)
HR (1) HRP20140839T1 (es)
JO (1) JO3083B1 (es)
MA (1) MA34868B1 (es)
MD (1) MD4275C1 (es)
MX (1) MX2012014321A (es)
MY (1) MY160928A (es)
PE (1) PE20131325A1 (es)
PL (1) PL2607354T3 (es)
PT (1) PT2607354E (es)
RS (1) RS53470B (es)
SA (1) SA112340106B1 (es)
SG (1) SG191498A1 (es)
SI (1) SI2607354T1 (es)
TW (1) TWI440628B (es)
UA (1) UA111156C2 (es)
UY (1) UY34508A (es)
WO (1) WO2013093333A1 (es)
ZA (1) ZA201209369B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2988720B1 (fr) * 2012-03-27 2014-03-14 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868775B1 (fr) * 2004-04-13 2008-04-11 Servier Lab Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868776B1 (fr) * 2004-04-13 2008-04-18 Servier Lab Nouveau procede de synthese de derives de la 1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2870537A1 (fr) * 2004-05-19 2005-11-25 Servier Lab Nouveau procede de synthese du (1s)-4,5-dimethoxy-1-(methyl aminomethyl-)-benzocyclobutane et de ses sels d'addition, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
RU2473544C2 (ru) * 2007-05-30 2013-01-27 Инд-Свифт Лабораториз Лимитед Способ получения ивабрадина гидрохлорида и его полиморфных модификаций
FR2920773B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2932800B1 (fr) * 2008-06-20 2015-02-20 Servier Lab Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2935381B1 (fr) * 2008-08-29 2010-12-17 Servier Lab Nouveau procede de resolution des enantiomerees du (3,4-dimethoxy-bicyclo°4.2.0!octa-1,3,5-trien-7-yl)nitrile et application a la synthese de l'ivabradine
FR2940287B1 (fr) * 2008-12-24 2010-12-24 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.
FR2941695B1 (fr) * 2009-02-04 2011-02-18 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
WO2010096416A1 (en) * 2009-02-17 2010-08-26 Mallinckrodt Inc. Process for the reductive alkylation of normorphinans
FR2943668B1 (fr) * 2009-03-31 2011-05-06 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.

Also Published As

Publication number Publication date
MD4275B1 (en) 2014-02-28
GEP20156245B (en) 2015-02-10
JP2013129656A (ja) 2013-07-04
JP5531084B2 (ja) 2014-06-25
FR2984320B1 (fr) 2013-11-29
FR2984320A1 (fr) 2013-06-21
MA34868B1 (fr) 2014-02-01
UA111156C2 (uk) 2016-04-11
CN103172567B (zh) 2015-08-12
NZ604890A (en) 2014-03-28
MX2012014321A (es) 2013-06-19
SI2607354T1 (sl) 2014-10-30
HK1186734A1 (en) 2014-03-21
DK2607354T3 (da) 2014-10-13
EA021713B1 (ru) 2015-08-31
CY1115620T1 (el) 2017-01-04
PE20131325A1 (es) 2013-11-15
TWI440628B (zh) 2014-06-11
ES2516290T3 (es) 2014-10-30
EP2607354A1 (fr) 2013-06-26
KR20130071389A (ko) 2013-06-28
US20130158257A1 (en) 2013-06-20
AR089325A1 (es) 2014-08-13
PT2607354E (pt) 2014-08-27
TW201331183A (zh) 2013-08-01
JO3083B1 (ar) 2017-03-15
HRP20140839T1 (hr) 2014-10-24
ZA201209369B (en) 2013-08-28
AU2012261583B2 (en) 2014-01-16
AU2012261583A1 (en) 2013-07-04
CA2798633C (fr) 2014-08-19
MY160928A (en) 2017-03-31
PL2607354T3 (pl) 2014-10-31
SA112340106B1 (ar) 2015-07-09
WO2013093333A1 (fr) 2013-06-27
EP2607354B1 (fr) 2014-07-16
UY34508A (es) 2013-06-28
RS53470B (sr) 2014-12-31
US8507668B2 (en) 2013-08-13
EA201201571A1 (ru) 2013-07-30
CA2798633A1 (fr) 2013-06-20
CN103172567A (zh) 2013-06-26
SG191498A1 (en) 2013-07-31
MD4275C1 (ro) 2014-09-30
KR101479986B1 (ko) 2015-01-08
BR102012032562A2 (pt) 2013-11-12

Similar Documents

Publication Publication Date Title
PA8855501A1 (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable
EP2726670A4 (en) CATALYTIC CONVERSION OF BIOMASS
IT1401911B1 (it) Processo per la sintesi di acido 2,5-furandicarbossilico
IL236376B (en) Eicosapentaenoic acid ethyl ester for use as a medicament for reducing a risk of cardiovascular death
IT1401129B1 (it) Processo per la sintesi di composti benzotiadiazolici
BR112013003819A2 (pt) método para a síntese de moleculas contendo furano de fórmula i a partir de moléculas contendo furano de fórmula ii
UY32499A (es) Nuevo procedimiento de síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
SMT201500327B (it) Procedimento per la preparazione di esteri di acido (5-fluoro-2-metil-3-chinolin-2-ilmetil-indol-1-il)-acetico
HUE036319T2 (hu) 2-karboxamid-cikloamino-karbamidszármazékok szintézise
ITMI20120351A1 (it) Procedimento per la produzione di bicarbonato di sodio
UY33893A (es) Nuevo procedimiento de síntesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable
LT3395796T (lt) (3s,3s') 4,4'-disulfandiil-bis-(3-aminobutan-1-sulfonrūgšties) kristalinė trihidrato forma
UY32500A (es) Nuevo procedimiento de síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
UY34423A (es) Nuevo procedimiento de síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
EA201100230A1 (ru) Новый способ синтеза ивабрадина и его аддитивных солей с фармацевтически приемлемой кислотой
UY35108A (es) Nuevo procedimiento de síntesis del (2e)-3-(3,4-dimetoxifenil) prop-2-enonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
CL2012003579A1 (es) Procedimiento de sintesis de la ivabradina de formula (i) y de sus sales de adicion a un acido farmaceuticamente aceptable.
ITMI20121144A1 (it) Procedimento per la preparazione di un sale di un farmaco antinfiammatorio non steroideo
FR2968660B1 (fr) Procede de preparation d'une solution organique d'un peroxydicarbonate de dialkyle
IT1394296B1 (it) Metodo di sintesi dell'acido glicocolico.
MX345278B (es) Procedimiento de sintesis del 3,4-dimetoxibiciclo[4.2.0]octa-1,3,5 -trien-7-carbonitrilo, y aplicacion a la sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
UY35149A (es) Nuevo procedimiento de síntesis del 3 -(2-bromo-4,5-dimetoxifenil) propanonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
EP2791349A4 (en) SYNTHESIS OF N-ACETYL-D-NEURAMIC ACID
UY34685A (es) Nuevo procedimiento de síntesis de la ivabradinay de sus sales de adición a un ácido farmacéuticamente aceptable
UY35068A (es) Nuevo procedimiento de síntesis del 3-(2-bromo-4,5-dimetoxifenil)propanonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable